Media release: Travel-acquired infections and illnesses in Canadians: surveillance report

Submitted by Carlyn Zwarenstein on February 11, 2014 - 12:09

Travel-acquired infections and illnesses in Canadians: surveillance report from CanTravNet surveillance data, 2009–2011

Open Medicine

A peer-reviewed, independent, open-access journal.

FOR IMMEDIATE RELEASE

A new study published today in Open Medicine surveys the spectrum of illnesses that Canadians acquire when travelling abroad.

Only in the U.S., you say? Pity.

Submitted by Carlyn Zwarenstein on February 6, 2014 - 23:39

Speaking of crowdfunding research (as we did yesterday right here), the Kickstarter model (which you may have heard of; it is a wildly popular site where people can seek funding, usually in small amounts from many, many people, for just about any creative project you can imagine) has come to science.

OM in the Globe & Mail: caution needed on newly-approved drugs

Submitted by Carlyn Zwarenstein on January 29, 2014 - 14:10

Our latest study is garnering some attention, including in this article in the Globe & Mail. And on the Twittersphere! Join us at https://twitter.com/OpenMedicine or follow @OpenMedicine.

Media release: How Safe Are New Drugs? Market Withdrawal of Drugs Approved in Canada between 1990 and 2009

Submitted by Carlyn Zwarenstein on January 28, 2014 - 06:55

Open Medicine

A peer-reviewed, independent, open-access journal.

FOR IMMEDIATE RELEASE

A York University study of drug safety published today in Open Medicine shows that new drugs are often on the market in Canada for more than three years before they are withdrawn as unsafe, raising concerns about turning to the newest drugs available.

Access to vital information: drug safety edition

Submitted by Carlyn Zwarenstein on January 26, 2014 - 17:27

With the recent news that the main Health Canada research library in Ottawa has closed, with inter-library loans (i.e.

Luxury journals... time for a boycott?

Submitted by Carlyn Zwarenstein on January 1, 2014 - 18:39

This year´s Medicine Nobel Prize-winner, cell biologist Randy Schekman, published a commentary in the Guardian a few weeks ago arguing that the incentives that big journals—specifically, Science, Cell and Nature—offer distort the progress of science. (The author is the editor of an open access journal, eLife, which is funded by the Wellcome Trust, the Howard Hughes Medical Institute and the Max Planck Society).

The shredding of evidence: some holiday reading

Submitted by Carlyn Zwarenstein on December 16, 2013 - 16:51

Journalist Chris Turners new book, The War on Science: Muzzled Scientists and Wilful Blindness in Stephen Harper's Canada

Crispr-CAS9 and the promise of simple gene editing

Submitted by Carlyn Zwarenstein on December 10, 2013 - 14:00

A top story for this year has got to be the Crispr-CAS9 technique for targeted gene editing. Many of you will be aware of this exciting development in genetics.

Healthy food policies at risk

Submitted by Carlyn Zwarenstein on December 2, 2013 - 23:17

The Globe & Mail has a story about our most recent commentary, on the cluttering of Canadian federal government food policy committees with food sector representatives whose financial interest isn’ t necessarily the same as the public interest in policy supporting a healthy diet--and so better health for Canadians.

Pages